Instil Bio (TIL) Cash from Investing Activities (2020 - 2026)

Instil Bio's Cash from Investing Activities history runs 7 years deep, the most recent figure standing at -$317000.0 for Q1 2026.

• In Q1 2026, Cash from Investing Activities fell 103.3% year-over-year to -$317000.0; the TTM figure through Mar 2026 stood at $15.5 million (down 71.39% YoY), while the FY2025 annual figure was $25.5 million, down 52.8% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at -$317000.0, down from $7.8 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $77.9 million in Q1 2022, with the low at -$21.5 million in Q2 2022.
• The 5-year median for Cash from Investing Activities is $10.3 million (2023), against an average of $13.8 million.
• Peak annual rise in Cash from Investing Activities reached 952.96% in 2022, while the deepest fall reached 153.16% in 2022.
• Instil Bio's Cash from Investing Activities stood at $32.8 million in 2022, then slumped by 57.47% to $14.0 million in 2023, then fell by 6.81% to $13.0 million in 2024, then slumped by 39.86% to $7.8 million in 2025, then slumped by 104.05% to -$317000.0 in 2026.
• Business Quant data shows TIL's Cash from Investing Activities at -$317000.0 in Q1 2026, $7.8 million in Q4 2025, and $8.4 million in Q3 2025.